Tus-Pharmaceutical Group Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 000590?
Owner Type	Number of Shares	Ownership Percentage
State or Government	0	0%
Institutions	16,225,208	6.78%
Private Companies	110,788,551	46.3%
General Public	112,457,508	47%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 23 shareholders own 53.04% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
24.5%	Tus-Holdings Co., Ltd.	58,606,962	CN¥404.4m	0%	no data
19.1%	Hengyang Hongxiang State-owned Investment (holding) Group Co.Ltd	45,757,337	CN¥315.7m	44%	no data
1.9%	Beijing Huaqing Investment Co., Ltd.	4,544,451	CN¥31.4m	0%	no data
0.65%	JPMorgan Chase & Co, Brokerage and Securities Investments	1,564,050	CN¥10.8m	0%	no data
0.62%	China International Capital Corporation Hong Kong Asset Management Limited	1,485,463	CN¥10.2m	0%	0.06%
0.61%	Guosen Securities Co., Ltd., Asset Management Arm	1,450,711	CN¥10.0m	0%	0.13%
0.6%	Everbright Pramerica Fund Management Co. Ltd.	1,443,700	CN¥10.0m	0%	0.09%
0.6%	CITIC Securities Company Limited, Asset Management Arm	1,429,004	CN¥9.9m	0%	0.01%
0.55%	China Asset Management Co. Ltd.	1,321,413	CN¥9.1m	0%	no data
0.5%	Huatai Securities (Shanghai) Asset Management Co., Ltd.	1,195,013	CN¥8.2m	0%	0.08%
0.48%	Goldstate Capital Fund Management Co., Ltd.	1,154,800	CN¥8.0m	0%	0.19%
0.46%	Wanjia Asset Management Co., Ltd.	1,105,600	CN¥7.6m	0%	0.01%
0.43%	Morgan Stanley, Investment Banking and Brokerage Investments	1,028,240	CN¥7.1m	0%	no data
0.42%	GF Securities Asset Management Co.,Ltd.	1,014,802	CN¥7.0m	0%	0.1%
0.41%	Beijing SembooScience & Technology Co.,Ltd.	981,801	CN¥6.8m	0%	no data
0.4%	Shanghai Zijie Fund Management Co., Ltd.	958,200	CN¥6.6m	0%	no data
0.37%	Leiyang Leineng Industrial Co., Ltd	898,000	CN¥6.2m	0%	no data
0.36%	Barclays PLC Private Banking & Investment Banking Investment	869,112	CN¥6.0m	0%	no data
0.048%	SWS MU Fund Management Co., Ltd.	114,600	CN¥790.8k	0%	no data
0.017%	Fortune And Royal Asset Management Co., Ltd.	41,200	CN¥284.2k	0%	0.01%
0.013%	Hongde Fund Management Co., Ltd.	31,000	CN¥214.0k	0%	no data
0.0044%	E Fund Management Co., Ltd.	10,500	CN¥72.4k	0%	no data
0.0033%	ICBC Credit Suisse Asset Management Co., Ltd.	7,800	CN¥53.9k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/31 23:01
End of Day Share Price	2025/01/27 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Tus-Pharmaceutical Group Co., Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Yi Qu	Donghai Securities Co. Ltd.
Yaming Liu	Founder Securities Co., Ltd.
Chase Ding	HSBC